全部分类
  • ANI-7
ANI-7的可视化放大

ANI-7

ANI-7 是一种 AhR 途径的激活剂。ANI-7 抑制多种癌细胞的生长,并有选择地抑制 MCF-7 乳腺癌细胞的生长,GI50 为 0.56 μM。ANI-7 通过激活 AhR 途径诱导 CYP1 代谢单加氧酶,并在敏感的乳腺癌细胞系中诱导 DNA 损伤,检查点激酶 (Chk2) 激活,S 期细胞周期停滞和细胞死亡。

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

ANI-7的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 5mg
    ¥875.00
    700.00
    - +
  • 10mg
    ¥1675.00
    1340.00
    - +
  • 50mg
    ¥5012.00
    4010.00
    - +
  • 100mg
    ¥8525.00
    6820.00
    - +
  • 200mg
    ¥0.00
    0.00
    - +
  • 500mg
    ¥0.00
    0.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajcx16342
  • CAS: 931417-26-4
  • 别名:
  • 分子式: C13H8Cl2N2
  • 分子量: 263.12
  • 纯度: >98%
  • 溶解度: DMSO: 20.83 mg/mL (79.17 mM)
  • 储存: Store at -20°C
  • 库存: 现货

Background

ANI-7 is an activator of aryl hydrocarbon receptor (AhR) pathway. ANI-7 inhibits the growth of multiple cancer cells, and potently and selectively inhibits the growth of MCF-7 breast cancer cells with a GI50 of 0.56 μM. ANI-7 induces CYP1-metabolizing mono-oxygenases by activating AhR pathway, and also induces DNA damage, checkpoint Kinase 2 (Chk2) activation, S-phase cell cycle arrest, and cell death in sensitive breast cancer cell lines[1][2][3].



[1]. ilbert J, et al. (Z)-2-(3,4-Dichlorophenyl)-3-(1H-Pyrrol-2-yl)Acrylonitrile Exhibits Selective Antitumor Activity in Breast Cancer Cell Lines via the Aryl Hydrocarbon Receptor Pathway. Mol Pharmacol. 2018 Feb;93(2):168-177. [2]. Baker JR, et al. Dichlorophenylacrylonitriles as AhR Ligands That Display Selective Breast Cancer Cytotoxicity in vitro. ChemMedChem. 2018 Jul 18;13(14):1447-1458. [3]. Mark Tarleton, et al. Library synthesis and cytotoxicity of a family of 2-phenylacrylonitriles and discovery of an estrogen dependent breast cancer lead compound. ?Medicinal Chemistry Communication. January 20112. (1):31-37.

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算